Insilico modelling of quantitative structure–activity relationship of pGI50 anticancer compounds on K-562 cell line (original) (raw)
Activity and toxicity modelling of some NCI selected compounds against leukemia P388ADR cell line using genetic algorithm-multiple linear regressions
Stephen Abechi
Journal of King Saud University - Science, 2018
View PDFchevron_right
Prediction of anticancer molecules using hybrid model developed on molecules screened against NCI-60 cancer cell lines
harinder singh
BMC cancer, 2015
View PDFchevron_right
In silico modelling of quantitative structure–activity relationship of multi-target anticancer compounds on k-562 cell line
Stephen Abechi
Network Modeling Analysis in Health Informatics and Bioinformatics, 2018
View PDFchevron_right
Qsar Modelling of Some Anticancer Pgi50 Activity on Hl-60 Cell Lines
Prof. Paul Mamza,FPIN,FICCON,FCSN, FMSN, FIPMD.
2016
View PDFchevron_right
ANN-QSAR model for selection of anticancer leads from structurally heterogeneous series of compounds
Humberto Santana Santana
European Journal of Medicinal Chemistry, 2007
View PDFchevron_right
Quantitative structure–activity relationship study on potent anticancer compounds against MOLT-4 and P388 leukemia cell lines
Stephen Abechi
Journal of Advanced Research, 2016
View PDFchevron_right
Application of Quantitative Structure-Activity Relationships in the Prediction of New Compounds with Anti-Leukemic Activity
Francisco Torrens
International Journal of Molecular Sciences
View PDFchevron_right
Development of linear and nonlinear predictive QSAR models and their external validation using molecular similarity principle for anti-HIV indolyl aryl sulfones
Kunal Roy
Journal of Enzyme Inhibition and Medicinal Chemistry, 2008
View PDFchevron_right
Quantitative structure–activity relationship modeling for predication of inhibition potencies of imatinib derivatives using SMILES attributes
shahin ahmadi
Scientific Reports
View PDFchevron_right
Structure Activity Relationship of Antiproliferative Agents using Multiple Linear Regression
Leyte Winfield
Chemical Biology & Drug Design, 2009
View PDFchevron_right
Antiproliferative Activity Predictor: A New Reliable In Silico Tool for Drug Response Prediction against NCI60 Panel
Antonino Lauria
International Journal of Molecular Sciences
View PDFchevron_right
Analogue-based approaches in anti-cancer compound modelling: the relevance of QSAR models
g narahari sastry
Organic and Medicinal Chemistry Letters, 2011
View PDFchevron_right
Computational modeling tool for biological activity assessment of drug candidate
BRAMAH HAZELA
2018
View PDFchevron_right
LM-ANN-based QSAR model for the prediction of pEC50 for a set of potent NNRTI using the mixture of ligand–receptor interaction information and drug-like indexes
Nasser Goudarzi
Network Modeling Analysis in Health Informatics and Bioinformatics, 2020
View PDFchevron_right
Theoretical Prediction of Antiproliferative Activity against Murine Leukemia Tumor Cell Line (L1210). 3D-Morse Descriptor and its Application in Computational Chemistry
Yunierkis Pérez-Castillo
QSAR & Combinatorial Science, 2009
View PDFchevron_right
Theoretical Modelling for Investigating Some Active Compounds as Potent Inhibitors Against Lung Cancer: A Multi-Linear Regression Approach
momohjimoh idris ovaku
The Journal of Engineering and Exact Sciences
View PDFchevron_right
Quantitative Structure-Activity Relationships: A Novel Approach of Drug Design and Discovery
Sourabh Jain
View PDFchevron_right
A facile in silico drug design strategy based on reference listed drugs and computational modeling of novel anticancer therapeutics
Asha Thomas
Sanat Tasarim Dergisi
View PDFchevron_right
Computational evaluation of some compounds as potential anti-breast cancer agents
Stephen Abechi
2021
View PDFchevron_right
Computer-aided drug design and the biological evaluation of anti-cancer drugs
Razia Moorad
2016
View PDFchevron_right
Insilco study on the toxicity of anti-cancer compounds tested against MOLT-4 and p388 cell lines using GA-MLR technique
Stephen Abechi
Beni-Suef University Journal of Basic and Applied Sciences, 2016
View PDFchevron_right
Substructural Analysis of Antineoplastic Compounds in Respect of in Vivo Tumor Models
Ilza Pajeva, Evgeny Golovinsky
Quantitative Structure-Activity Relationships, 1990
View PDFchevron_right
Development of quantitative structure–activity relationship (QSAR) models to predict the carcinogenic potency of chemicals. II. Using oral slope factor as a measure of carcinogenic potency
Chandrika Moudgal
Regulatory Toxicology and Pharmacology, 2011
View PDFchevron_right
DESIGN OF LOW CYTOTOXICITY DIARYLANILINE DERIVATIVES BASED ON QSAR RESULTS: AN APPLICATION OF ARTIFICIAL NEURAL NETWORK MODELLING
Ihsanul Arief
View PDFchevron_right
Predictive QSAR model and clustering analysis of some Benzothiazole derivatives as cytotoxic inhibitors
Nadjib Melkemi
SDRP Journal of Computational Chemistry & Molecular Modelling
View PDFchevron_right
A Novel Approach for the Virtual Screening and Rational Design of Anticancer Compounds
Alina Montero
Journal of Medicinal Chemistry, 2000
View PDFchevron_right
In silico- internet and analogue based drug design of new anticancer agent
Ajay Bisht
The Pharma Innovation Journal, 2016
View PDFchevron_right
CORAL software: Prediction of carcinogenicity of drugs by means of the Monte Carlo method
Alla Toropova
European Journal of Pharmaceutical Sciences, 2014
View PDFchevron_right
Generation of artificial neural networks models in anticancer study
Miguel Fernandes
Neural Computing and Applications, 2013
View PDFchevron_right
Data Mining the NCI60 to Predict Generalized Cytotoxicity
Adam Lee
Journal of Chemical Information and Modeling - J CHEM INF MODEL, 2008
View PDFchevron_right